Clinical Trial Update: Identification of Early Markers for ALS [NA]

View source ↗

Summary

A France-sponsored clinical trial is currently recruiting to identify early markers for amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Amyotrophic Lateral Sclerosis (ALS) | NA | Status: RECRUITING